Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Viscido

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
United European Gastroenterology Journal|October 14, 2017
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free dietDolores Gabrieli, Fabiana Ciccone, Annalisa Capannolo, et al.
Therapeutic Advances in Gastroenterology|October 21, 2017
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazineGiuseppe Frieri, Brigida Galletti, Mirko Di Ruscio, et al.
Acta Bio-Medica : Atenei Parmensis|May 16, 2019
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literatureRosa Manetta, Ilaria Capretti, Noemi Belleggia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2019
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Gionata Fiorino, Flavio Caprioli, Marco Daperno, et al.
Journal of Crohn'S & Colitis|January 30, 2014
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomyRita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2025
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensusGionata Fiorino, Flavio Andrea Caprioli, Sara Onali, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Inflammatory Bowel Diseases|October 8, 2020
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 SurveyMassimo Caludio Fantini, Livia Biancone, Gabriele Dragoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2025
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Nicola Cersullo, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
United European Gastroenterology Journal|October 14, 2017
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free dietDolores Gabrieli, Fabiana Ciccone, Annalisa Capannolo, et al.
Therapeutic Advances in Gastroenterology|October 21, 2017
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazineGiuseppe Frieri, Brigida Galletti, Mirko Di Ruscio, et al.
Acta Bio-Medica : Atenei Parmensis|May 16, 2019
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literatureRosa Manetta, Ilaria Capretti, Noemi Belleggia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2019
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Gionata Fiorino, Flavio Caprioli, Marco Daperno, et al.
Journal of Crohn'S & Colitis|January 30, 2014
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomyRita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2025
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensusGionata Fiorino, Flavio Andrea Caprioli, Sara Onali, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Inflammatory Bowel Diseases|October 8, 2020
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 SurveyMassimo Caludio Fantini, Livia Biancone, Gabriele Dragoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2025
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Nicola Cersullo, et al.
Pageof 8